Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2013-07-02 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13003), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DES DEUX PLACES : revenue, balance sheet and financial ratios
SELARL PHARMACIE DES DEUX PLACES is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13003),
this company of category PME
shows in 2022 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DES DEUX PLACES (SIREN 794109397)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
2 079 714 €
N/C
N/C
N/C
N/C
Net income
156 199 €
31 539 €
-27 198 €
115 111 €
44 215 €
32 572 €
22 090 €
97 018 €
EBITDA
N/C
N/C
N/C
130 819 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
5.5%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE DES DEUX PLACES generates positive net income of 156 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 97 k€ -> 156 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
156 199 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 160%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 27%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
159.761%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
26.575%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DES DEUX PLACES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
77.68
794.796
497.255
349.228
207.622
-2396.053
1819.607
159.761
Financial autonomy
44.606
8.504
9.707
11.569
18.855
-2.595
3.374
26.575
Repayment capacity
None
None
None
None
2.027
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
6.25%
None%
None%
None%
Sector positioning
Debt ratio
159.762025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+50 pts over 3 years
In 2025, the debt ratio of SELARL PHARMACIE DES DEUX... (159.76) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
26.57%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of SELARL PHARMACIE DES DEUX... (26.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 221.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
221.929
Liquidity indicators evolution SELARL PHARMACIE DES DEUX PLACES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
203.011
135.899
103.881
110.15
157.903
155.29
153.255
221.929
Interest coverage
None
None
None
None
0.276
None
None
None
Sector positioning
Liquidity ratio
221.932025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+29 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE DES DEUX... (221.93) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DES DEUX PLACES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
41 948 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
17
0
0
0
Customer payment term (days)
0
0
0
0
7
257
0
0
Supplier payment term (days)
0
0
0
0
38
946
0
0
Positioning of SELARL PHARMACIE DES DEUX PLACES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DES DEUX PLACES is estimated at
2 481 239 €
(range 1 683 780€ - 3 893 406€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1683k€2481k€3893k€
2 481 239 €Range: 1 683 780€ - 3 893 406€
NAF 5 année 2025
Valuation method used
Net Income Multiple
156 199 €
×
15.9x
=2 481 240 €
Range: 1 683 781€ - 3 893 407€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DES DEUX PLACES with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DES DEUX PLACES
What is the revenue of SELARL PHARMACIE DES DEUX PLACES ?
The revenue of SELARL PHARMACIE DES DEUX PLACES in 2022 is 2.1 M€.
Is SELARL PHARMACIE DES DEUX PLACES profitable?
Yes, SELARL PHARMACIE DES DEUX PLACES generated a net profit of 156 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DES DEUX PLACES ?
The headquarters of SELARL PHARMACIE DES DEUX PLACES is located in MARSEILLE (13003), in the department Bouches-du-Rhone.
Where to find the tax return of SELARL PHARMACIE DES DEUX PLACES ?
The tax return of SELARL PHARMACIE DES DEUX PLACES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DES DEUX PLACES operate?
SELARL PHARMACIE DES DEUX PLACES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart